All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Chugai Pharmaceutical Co., Ltd. revenue reports

Chugai Pharmaceutical Co., Ltd. financial reports, Chugai Pharmaceutical Co., Ltd. annual revenue in 2022. When does Chugai Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets

Chugai Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in Euro today

Net revenue of Chugai Pharmaceutical Co., Ltd. on 30/06/2021 amounted to 221 411 000 000 €. The dynamics of Chugai Pharmaceutical Co., Ltd. net revenue increased by 52 594 000 000 € from the last reporting period. Net income, revenue and dynamics - the main financial indicators of Chugai Pharmaceutical Co., Ltd.. Chugai Pharmaceutical Co., Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Chugai Pharmaceutical Co., Ltd. net income is shown in blue on the graph. A graph of the value of all Chugai Pharmaceutical Co., Ltd. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 193 903 340 182 € +33.38 % ↑ 61 939 143 212 € +106.66 % ↑
31/03/2021 147 843 513 554 € +9.42 % ↑ 41 520 752 182 € +35.34 % ↑
31/12/2020 184 283 094 612 € +18.66 % ↑ 45 809 358 696 € +30.23 % ↑
30/09/2020 182 508 800 800 € +10.52 % ↑ 52 662 196 346 € +24.91 % ↑
31/12/2019 155 301 502 746 € - 35 174 980 730 € -
30/09/2019 165 138 937 292 € - 42 160 058 442 € -
30/06/2019 145 373 864 714 € - 29 972 078 688 € -
31/03/2019 135 119 567 456 € - 30 678 818 622 € -
Show:
to

Chugai Pharmaceutical Co., Ltd. financial report charts

The latest dates of Chugai Pharmaceutical Co., Ltd. financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Chugai Pharmaceutical Co., Ltd. is 30/06/2021. Gross profit Chugai Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Chugai Pharmaceutical Co., Ltd. is 153 352 000 000 €

Chugai Pharmaceutical Co., Ltd. quarterly report dates

Cost of revenue Chugai Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Chugai Pharmaceutical Co., Ltd. is 68 059 000 000 € Total revenue Chugai Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Chugai Pharmaceutical Co., Ltd. is 221 411 000 000 € Operating income Chugai Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Chugai Pharmaceutical Co., Ltd. is 96 712 000 000 €

Net income Chugai Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Chugai Pharmaceutical Co., Ltd. is 70 726 000 000 € Current assets Chugai Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Chugai Pharmaceutical Co., Ltd. is 857 123 000 000 € Total assets Chugai Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Chugai Pharmaceutical Co., Ltd. is 1 275 767 000 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
134 299 854 224 € 99 380 595 998 € 120 996 153 682 € 121 767 700 004 € 99 191 431 406 € 100 315 034 052 € 89 262 041 850 € 79 151 369 560 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
59 603 485 958 € 48 462 917 556 € 63 286 940 930 € 60 741 100 796 € 56 110 071 340 € 64 823 903 240 € 56 111 822 864 € 55 968 197 896 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
193 903 340 182 € 147 843 513 554 € 184 283 094 612 € 182 508 800 800 € 155 301 502 746 € 165 138 937 292 € 145 373 864 714 € 135 119 567 456 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
84 696 694 544 € 56 018 992 092 € 64 729 320 944 € 75 919 807 780 € 43 542 010 878 € 57 647 909 412 € 42 876 431 758 € 40 367 373 628 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
61 939 143 212 € 41 520 752 182 € 45 809 358 696 € 52 662 196 346 € 35 174 980 730 € 42 160 058 442 € 29 972 078 688 € 30 678 818 622 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
29 392 324 244 € 26 033 776 974 € 28 753 017 984 € 26 398 093 966 € 27 175 770 622 € 21 971 992 818 € 23 367 957 446 € 22 015 780 918 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
109 206 645 638 € 91 824 521 462 € 119 553 773 668 € 106 588 993 020 € 111 759 491 868 € 107 491 027 880 € 102 497 432 956 € 94 752 193 828 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
750 635 752 726 € 648 914 244 902 € 731 178 948 372 € 650 105 281 222 € 612 753 156 160 € 585 043 170 718 € 555 448 545 452 € 524 484 228 418 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 117 268 259 454 € 1 002 420 830 774 € 1 082 002 199 476 € 994 960 214 296 € 927 357 518 230 € 897 950 306 032 € 864 044 304 440 € 816 422 118 404 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
163 882 218 822 € 141 916 356 338 € 185 953 172 746 € 160 011 350 782 € 178 603 778 042 € 155 029 140 764 € 130 633 038 730 € 110 186 623 316 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 156 996 102 216 € 156 122 967 502 € 139 761 106 056 € 119 561 655 526 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 179 469 906 660 € 185 836 696 400 € 170 296 299 710 € 150 436 644 836 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 19.35 % 20.70 % 19.71 % 18.43 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
921 352 418 196 € 860 530 747 296 € 858 249 387 286 € 810 316 305 740 € 747 887 611 570 € 712 113 609 632 € 693 748 004 730 € 665 985 473 568 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 68 841 899 296 € 54 942 680 594 € 28 248 579 072 € 28 935 176 480 €

Last revenue report of Chugai Pharmaceutical Co., Ltd. was 30/06/2021. According to last financial report total revenue in Chugai Pharmaceutical Co., Ltd. was 193 903 340 182 Euro and changed by +33.38% since last year. Net income in Chugai Pharmaceutical Co., Ltd. was 61 939 143 212 € in last quartal, net income changes to +106.66%.

Current cash Chugai Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Chugai Pharmaceutical Co., Ltd. is 187 131 000 000 €

Chugai Pharmaceutical Co., Ltd. stocks data

Chugai Pharmaceutical Co., Ltd. financials